Cleared Special

Barrx SB RFA Endoscopic Catheter (K173559) - FDA 510(k) Clearance

Class II Gastroenterology & Urology device cleared through the Special 510(k) pathway - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2018
Decision
62d
Days
Class 2
Risk

K173559 is an FDA 510(k) clearance for the Barrx SB RFA Endoscopic Catheter. Classified as Unit, Electrosurgical, Endoscopic (with Or Without Accessories) (product code KNS), Class II - Special Controls.

Submitted by Covidien, LLC (Mansfield, US). The FDA issued a Cleared decision on January 18, 2018 after a review of 62 days - a notably fast clearance cycle.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.4300 - the FDA gastroenterology and urology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Covidien, LLC devices

Submission Details

510(k) Number K173559 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 17, 2017
Decision Date January 18, 2018
Days to Decision 62 days
Submission Type Special
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
68d faster than avg
Panel avg: 130d · This submission: 62d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code KNS Unit, Electrosurgical, Endoscopic (with Or Without Accessories)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.4300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - KNS Unit, Electrosurgical, Endoscopic (with Or Without Accessories)

All 91
Devices cleared under the same product code (KNS) and FDA review panel - the closest regulatory comparables to K173559.
Fusion OMNI Sphincterotome
K172288 · Wilson-Cook Medical Inc./Cook Endoscopy · Apr 2018
Habib EndoHPB
K180165 · Emcision , Ltd. · Mar 2018
Rezum System
K180237 · Nxthera, Inc. · Feb 2018
Single Use Electrosurgical knife
K171158 · Olympus Medical Systems Corp. · Nov 2017
Single Use Sphincterotome V (Distal Wireguided) KD-VC412Q-0215
K160241 · Olympus Medical Systems Corp. · Mar 2016
Single Use Balloon Dilator V (with Knife)
K150142 · Olympus Medical Systems Corp. · Oct 2015